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bstract
Supercritical fluid impregnation was tested to prepare a new ophthalmic drug delivery device. Poly(methylmethacrylate-co-ethylhexylacrylate-
o-ethyleneglycoldimethacrylate), P(MMA-EHA-EGDMA) has been proposed by Mariz [M. Mariz, Preparac¸a˜o de uma lente intra-ocular dotada
e um sistema de libertac¸a˜o controlada de fa´rmaco, Master Thesis, Universidade de Coimbra, 1999] as a promising matrix to be used for
ntraocular delivery of anti-inflammatory drugs used in eye surgery. This matrix was successfully impregnated with flurbiprofen, a non-steroidal
nti-inflammatory agent.
The success of the impregnation was evaluated by scanning electron microscopy (SEM) analysis and also by in vitro drug release studies. The
ffect of some operating parameters was evaluated, namely, pressure and contact time. The operating pressure will influence both the solubility of
he drug in the supercritical fluid but also the sorption degree of the polymeric matrix in the presence of carbon dioxide. The solubility of the drug
n carbon dioxide and the sorption degree are reported in previous studies. A comparison between the batch and the semi-continuous impregnation
rocess is also presented.
The supercritical fluid impregnation proved to be feasible for the preparation of a new ophthalmic drug delivery system. The drug release
rofiles suggest that the drug can be released up to three months, which is a major advantage for the prevention of the inflammatory response after
phthalmic surgery.
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. Introduction
Cataract is the most common treatable form of blindness
orldwide and the most frequent form of ophthalmic surgical
rocedure is to extract the cataract with subsequent implant of an
ntra-ocular lens (IOL) to compensate the loss of the natural crys-
alline lens. Poly(methylmethacrylate-co-ethylhexylacrylate-
o-ethyleneglycoldimethacrylate), P(MMA-EHA-EGDMA)
as been proposed by Mariz [1] as a promising matrix to be
sed for intraocular delivery of anti-inflammatory drugs used
n eye surgery. The inflammatory response of the ocular tissues
∗ Corresponding author. Tel.: +351 21 446 97 28.








896-8446/$ – see front matter © 2007 Elsevier B.V. All rights reserved.
oi:10.1016/j.supflu.2007.01.007drug delivery
n a common-side effect associated to ophthalmic surgery. It
an interfere with the normal function of the eye, whose optic
ransparency must be maintained [2]. Most ocular diseases are
reated with optical application of drug solutions administered
s eye drops. These medications present several problems
nd/or limitations, like poor drug bioavailability and systemic
oxicity, derived essentially from two main features: ocular
natomical and physiological constraints, and pharmacokinetic
nd other carrier limitations. Poor ocular drug bioavailability
s due essentially to the relative impermeability of the corneal
embrane, to tear dynamics, blinking and nasolacrimal
rainage, and to the high efficiency of the blood-ocular barrier.
n the case of eye drops medication, only 5% of the applied
rug actually penetrates the cornea [3]. The initial high drug
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ue mainly to drainage, usually forces clinicians to recommend
requent drug dosing, at high concentrations, in order to
void poor drug bioavailability but causing a potential risk of
ystemic toxicity. Therefore, topical eye drops are an ineffective
elivery system, with an active principle concentration of 20
imes higher than the effectively needed; some of the drug not
bsorbed by the cornea will reach the bloodstream, as tear
ynamics and nasolacrimal duct drainage are also a major
ay of entry into the circulatory system which may cause
ndesired and toxic systemic side-effects. In most cases, the
elivery of ocular drugs to the posterior segment of the eye
s diminished by the same factors that are responsible for the
oor ocular bioavailability and also by the blood-retinal barrier
hich limits the intravenous route in posterior drug delivery
4–6]. However, topical eye drops accounts for almost 90% of
he commercially available therapeutic ophthalmic products
ecause of its favorable costs, simplicity of formulation and
elf-application, and good acceptance by patients, despite the
eferred disadvantages and related risks. Several efforts have
een made in order to improve the ocular delivery of topically
pplied ocular drugs and to reduce their disadvantages and
dverse effects [4,6].
Controlled drug delivery products, using biocompatible or
iodegradable polymers, have received considerable attention
n the last years. These substances are generally used for the
reparation of controlled release formulations, which, therefore
llow to control the rate of assumption of the drug by the body
mproving its pharmacokinetic profile. In fact, there is a growing
nterest of the pharmaceutical industry in the development of
hese systems [7].
The preparation of drug release products necessitates the use
f a mobile phase that dissolves and carries the drug component,
hich also swells and stretches the polymer matrix, facilitating
he diffusion of the drug and increasing the rate of impregnation.
onventionally, the preparation of these systems involves three
teps: solubilization of the pharmaceutical in an appropriate sol-
ent, diffusion of the pharmaceutical through the polymer and
limination of the residual solvent.
Impregnation using supercritical fluid technology has proven
o be feasible when the pharmaceutical compound is soluble in
arbon dioxide and the polymer can be swollen by the super-
ritical fluid. A high purity product, free of residual solvents is
btained, since no organic solvents are involved in the impregna-
ion process [8,9]. Supercritical fluids, especially supercritical
arbon dioxide (scCO2) have been identified as prime candi-
ates to develop alternative clean processes for the preparation
f drug-loaded polymeric matrixes [10]. Furthermore, the use of
upercritical fluids can take advantage of their high diffusivity
n polymers, in combination with the high solubility and plas-
icizing action. Therefore, compressed CO2 can be used as a
olvent to carry the drug into biocompatible polymers. More-
ver, when depressurisation occurs, the gas rapidly diffuses out
f the polymer, deplasticizing it and warranting the complete
emoval of solvent, without exposing polymers and drugs to
igh temperatures, which may degrade them [11,12].
In this work, the possibility of impregnating P(MMA-EHA-
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rug in carbon dioxide had been previously studied, as well as
he sorption degree of this polymeric matrix in the presence of
arbon dioxide. The aim of this study was to evaluate the effects
f these two variables in the impregnation process, in order to
etermine the best operating conditions. The percentage of drug
mpregnated in the films as well as the release profiles of the drug
ut of the film were evaluated and the results are presented.
. Experimental procedure
.1. Materials
P(MMA-EHA-EGDMA) samples were synthesized by bulk
ree radical polymerization, and according to the method
escribed below [1]. Flurbiprofen, (2-fluoro-alpha-methyl-4-
iphenylacetic acid), CAS [5104-49-4], (97% purity) was
urchased from Sigma–Aldrich. Carbon dioxide (99.5%, indus-
rial grade) was obtained from Air Liquide (France). All products
ere used with no further purification.
.2. Polymerization
Reaction mixtures were prepared weighing the liquid
onomers and the thermal initiator. The reticulated copolymer
(MMA-EHA-EGDMA) was prepared adding 40% of MMA,
0% EHA and 7.5% (weight % of total mass of MMA + EHA)
f the reticulating monomer, EGDMA. Benzoyl peroxide was
sed as initiator with 1% concentration (molar % of total moles
f MMA + EHA). MMA’s stabilizer was previously removed by
iquid–liquid extraction.
Reaction mixtures were magnetically stirred for 10 min until
enzoyl peroxide was completely dissolved. Then, the resulting
ixtures were spread between glass plates, separated with sili-
one rubber spacers, in order to produce fine polymer films of
niform thickness (∼1 mm). Polymerization reactions were car-
ied out for three hours, in a heated oven, at 80 ◦C. The obtained
amples were cut in circular shape samples (9.0 mm diameter).
ll samples were vacuum dried and weighted, until constant
ass is achieved (in order to remove any possible monomer
esidue still present).
.3. Supercritical fluid impregnation process
The procedure is similar to the one described by Diankov
13] and the impregnation apparatus is schematically presented
n Fig. 1.
The equipment consists basically in a saturator, S, an impreg-
ation vessel, I. S and I are tubular vessels (of 5 and 10 mL,
espectively) placed in an air oven (Touzard et Matignon, model
TE Binder) that maintains the temperature within ±1 ◦C.
he fluid temperature is measured by means of a thermocouple
WATLOW, 965 series). CO2 was liquefied through a cooling
nit CU (Colora, model WK15), and compressed to the
perating pressure with a pump (Gilson, 308). The fluid was
reheated to the desired temperature in a heat exchanger, HE,
efore entering the saturator. The pressure of the system is
easured with a pressure transducer inline with the saturator






































































aFig. 1. Supercritical fluid impregnation apparatus, (S) saturator, (I
nd the impregnation vessel (ASCO, model PR711F). The
aturator was loaded with a few grams of pharmaceutical drug
nd small glass beads to enhance the mass transfer and the
mpregnation vessel was loaded with the polymer. A typical
mpregnation experiment started by stabilizing the system with
O2 during a period of 2 h, to achieve the maximum sorption
egree of the polymer, and also to promote the solubilization
f the drug in carbon dioxide. Valves 1, 2 and 3 were kept open
nd 4, 5 and 6 closed, during the swelling period. Then, the CO2
as allowed to flow through the vessels for a selected period of
ime. Valves 1, 2, 4 and 5 were opened and 3 was closed during
he impregnation step. The carbon dioxide flow was maintained
onstant for all experiments performed (∼1 SLPM) and it
as controlled by means of a metering valve. The flow was
easured by a flow meter (Kobold, model MAS 4009). At the
nd of the flow period, the system was slowly depressurized.
The batch impregnation process was carried out in the same
pparatus but in this case both, the polymer and the drug were
oaded in the same vessel. Flurbiprofen was loaded in the bottom
f the cell and it was separated from the polymeric matrixes with
cotton layer in order to prevent contact of the two and thus, the
ontamination of the surface of the films with the powder. The
essel was set at the desired operational conditions (T and P)
nd the impregnation took place for the pre-determined period.
.4. Film characterization
.4.1. Scanning electron microscopy (SEM)
The morphology of polymer samples was analysed and
maged by scanning electron microscopy (SEM, Leica 5440)
fter carbon sputter coating.
.4.2. In vitro release studies
Polymeric impregnated films were suspended in 40 mL of
imulated lacrimal fluid (prepared according to USPharmaco-
ea 26) stirred at 150 rpm at 37 ◦C. Aliquots of 500L were
ithdrawn in predetermined time intervals and the same vol-
me of fresh medium was added to the suspension. The samples
ere filtered (0.45 mm, milipore filters) and analysed by HPLCMerck Hitachi consisting of a L-6200 pump, A-2000 autosam-
ler, L-4200 UV–vis detector and a T-6300 column thermostat).
C8 column (Merck, Lichrospher 250-4, 5m) and a pre-




oregnation vessel, (P) pressure transducer, (T) temperature sensor.
mobile phase consisting of 1.4 g of monobasic sodium phos-
hate monohydrate (p.a. Panreac) in 570 mL of deionised water
nd 430 mL of acetonitrile (HPLC grade, Lab-Scan) adjusted to
H 3 with phosphoric acid (85% Panreac). The flow rate was
.5 mL/min and the volume injected 50L. Detection was at
54 nm and the quantification was by external standard calibra-
ion. The retention time of flurbiprofen under these conditions
as 8.3 min. Calculations of the amount of drug released took
nto account replacement of aliquots with fresh medium.
. Results
The characterization of the binary systems drug—CO2 and
O2-polymer is essential for the determination of the best
perating conditions. Solubility data of flurbiprofen is reported
reviously [14] as well as the sorption of the carbon dioxide in
he polymeric matrix [15,16]. Drug solubility is defined as the
mount of solute (drug) that can be dissolved in a certain amount
f solvent (supercritical fluid) at certain operational conditions
pressure and temperature). The sorption degree was defined to
e the ratio between the mass of carbon dioxide in the sam-
le and total mass (mass of polymeric sample + mass of carbon
ioxide). The solubility of flurbiprofen in scCO2 at the opera-
ional conditions tested and the sorption of carbon dioxide in P
MMA-EHA-EGDMA) are reported in Table 1.
Impregnation experiments were performed either in a batch
r semi-continuous mode in order to evaluate the performance of
hese two techniques. The experiments were carried out at pres-
ures ranging from 100 to 180 bar and temperatures from 308
o 313 K. Also, different contact times during the impregnation
rocess were studied (Table 1).
The resulting impregnated polymer films were cut into
ections and characterized using SEM. Two examples of impreg-
ated polymers are presented in Fig. 2(a and b).
As it can be seen from the SEM images, the drug is more
omogeneously dispersed within the matrix when the batch
rocess was performed.
Furthermore, the sample processed in batch mode presents
higher impregnation yield, than the one prepared using aemi-continuous method. The percentage of impregnation is
efined as the relative quantity of dug in an impregnated sam-
le, expressed in w/w percentage. It is probable that the flow rate
f 2 mL/min is too high to get a contact time long enough for
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Table 1
Summary of the operational conditions of the experiments performed









1 180 35 2 3 60 0.34 0.22
2 150 35 2 3 57 0.26 0.27
3 100 35 2 3 49 0.11 0.37
4 180 35 2 5 60 0.34 0.32




































aFig. 2. SEM images of
he concentration in the fluid phase to approach the equilibrium
alue. Thus, the poor mass transfer of dissolution and impreg-
ation due to this too high flow rate does not ensure a contact
ime equivalent to the one in the batch process.
Another parameter that greatly influences the amount of drug
mpregnated is the contact time. Increasing the impregnation
ime, there is also an increase in the percentage of drug impreg-
ated in the polymeric matrix. However, when the batch process
as performed better impregnation yields were achieved, even
t a shorter contact time. The high carbon dioxide flow, in the
emi-continuous process can be one of the reasons for the results
btained (Table 1).
In Fig. 3, the effect of pressure in the impregnation yield
an be evaluated. Comparing the percentage of impregnation
f the experiments performed at different pressures it can be
oncluded that at higher pressures lead to a lower percent of
mpregnation. This represents also the trend of the percent-
ge of impregnation versus the sorption degree of the polymer.lower sorption degree favours the process, therefore lower
perational pressures should be used for higher impregnation
ields.














timents (a) 1 and (b) 5.
Kazarian et al. [12,17,18] distinguish two mechanisms of
mpregnation assisted by supercritical fluids. The first mecha-
ism corresponds to a simple deposition of the compound when
he fluid leaves the swollen matrix. In this case, the solute is
olubilized in carbon dioxide and the polymer is exposed to this
olution for a predetermined period followed by depressuriza-
ion of the system. When the system is depressurised, carbon
ioxide molecules quickly leave the polymer matrix, leaving
he solute trapped inside. As reported by Kazarian, it concerns
ostly solute with a relatively high solubility in the fluid and it
s specific to impregnation carried out on a matrix subjected to
welling upon exposure to supercritical fluid. The second effect,
ot specific to supercritical fluids, corresponds to chemical inter-
ctions (like van der Waal’s interactions) between the solute and
he matrix, that would favour the preferential partitioning of the
olute with the polymer phase.
Flurbiprofen has a rather high solubility in carbon dioxide
nd it increases with pressure. Additionally, the sorption of car-
on dioxide in the matrix also increases with pressure for a
ertain temperature. So it would be expected an increase of the
olute uptake with pressure, on the basis that the more the CO2
s loaded with the drug and the easier it goes inside the poly-
er, the larger should be the drug uptake. But, it is the contrary
hat is observed. Indeed, the experiments show that these two
ffects when combined do not favour the impregnation pro-
ess. This might be due to stronger interactions of the drug
or the solvent (carbon dioxide) than for the polymeric matrix
hat is poorly impregnated. As reported in previous works by
ubra-Paternault and co-workers [19,20] at higher densities (or
igher temperatures), the interactions between the solute and
he carbon dioxide molecules increase and are detrimental to
he bonding forces between the solute and the matrix, therefore













































[ig. 4. Release profiles of the impregnated samples (experiments 1 and 5).
t higher pressures and temperatures the impregnation yield is
ower.
The drug release profiles were similar for all the impregnated
amples and an example is given in Fig. 4.
The release profiles of the samples prepared prove the
uccess of the impregnation process and indeed, P(MMA-EHA-
GDMA) might be used as a new ophthalmic drug delivery
evice. It is also relevant the fact that flurbiprofen is still being
eleased up to more than three months. This can present an enor-
ous advantage for the prevention of the inflammatory response
fter ophthalmic surgery.
. Conclusions
P(MMA-EHA-EGDMA) was successfully impregnated with
urbiprofen, an anti-inflammatory agent. Different experimen-
al conditions were tested and the results obtained suggest that
he best impregnating conditions for this system are low tem-
eratures and pressures, which at the same time correspond to a
ower solubility of the drug in the supercritical fluid and a low
welling of the polymeric matrix.
Impregnation efficiency results from a complex mechanism
hat, in turn, involves interactions between the solute, the carrier
nd the matrix. The relative strength of all binary interactions
ill contribute to the final partitioning of the solute between the
obile phase and the solid. In the case of the polymer and drug
tudied in this work, results suggest that the interactions between
he drug and the fluid phase are stronger than the ones of the drug
o the polymeric matrix, therefore lower solvent densities favour
he impregnation process.
Experiments performed also indicate that the batch impregna-
ion process leads to higher yields of impregnation and according
o the release profiles obtained the drug can be released from the
atrix up to three months, which presents great advantages for
ost-surgical treatments.
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